Skip to content

Application of VR-based Working Memory Screening Test

Application of VR-based Working Memory Screening Test to Facilitate Early Detection of Dementia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04600726
Acronym
VR
Enrollment
160
Registered
2020-10-23
Start date
2021-02-01
Completion date
2022-12-31
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Age-matched Older Adults, Older Adults With Mild Neurocognitive Disorders, Older Adults With Non-communicable Diseases

Keywords

Cognitive function screening

Brief summary

We propose to validate an interactive, immersive spatial memory test from the laboratory test. This VR-based working memory test (VRWMT) is a first-person, self-pacing game embedded within a virtual reality environment, the program is easily implemented with minimal instructions and no supervision that can be community-users friendly. It is specifically designed to assess rapid spatial working memory - a common deficit in all NCD subtypes. Its ability to detect pathological models of dementia, age-related deterioration, and hippocampal dysfunction are well established in literature

Detailed description

The proposed research aims to study the ability of VRWMT to discriminate between older adults with known mild NCD, healthy age-matched older adults and participants with non-communicable diseases and to predict their deterioration in cognitive function over a period of 12 months. Moreover, this study is to characterize and evaluate any concurrent validity between emergence of deterioration in the VRWMT and clinical tools of functional performance in older adults. Additionally, the potential of inflammatory and metabolic dysregulation biomarkers to increase our ability to detect early NCD risk over and above the predictive validity of the VRWMT. The study findings will bring both social and clinical significance to ageing and NCD research. The combination of behavioural and biomarkers of pathological significance offers an innovative approach that potentially addresses the limitations intrinsic to either measure alone.

Interventions

OTHERno intervention

no interventioni

Sponsors

Department of Neuroscience, Psychology and Behavior. The University of Leicester
CollaboratorUNKNOWN
School of Psychology, The University of Nottingham
CollaboratorUNKNOWN
The Alice Ho Miu Ning Nethersole Hospital
CollaboratorUNKNOWN
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* the ability to understand verbal and written Chinese instructions * the ability and willingness to provide informed consent and sign the relevant document.

Exclusion criteria

* a history of substance abuse including alcohol, drugs, or any medication/substances indicative of chronic abuse; * participants with major NCD.

Design outcomes

Primary

MeasureTime frameDescription
Delayed matching-to-place (DMP)20 minsa prototypical working memory test implemented in a virtual reality environment of the VRWMT
The Montreal Cognitive Assessment - Hong Kong Version15 minsThe MoCA-HK is an examiner-rated cognitive screening test that evaluates visuospatial functions, naming, attention and working memory, language, abstraction, and orientation, commonly affected in NCD including Alzheimer's disease, stroke, and vascular dementia. It is a validated tool for detecting cognitive impairment in Chinese Hong Kong population at early stages. It is a common tool in practical practice that can be under 15 minutes. MoCA scores range from 0 to 30. Subjects with a score of above 21 will be classified as healthy controls, while 21 or below will be included in the mild NCD group in the present study.
The Chinese Multiple Errands Test20 minsA functional performance measure of executive function that identifies abnormalities known for its ecological validity through assessment of real-world daily living activities. The proposed study will evaluate the ability of working memory (as a component to executive function) from VRWMT to predict executive functions (globally) across the six scores obtained from the Chinese Multiple Errands Test
Biological biomarkers for older adults with NCDs and Healthy Control5 minsThe panel of biomarkers covers five immune cytokines and two metabolic markers (including serum IL-1B,Interleukin 6, Interleukin 10, Interleukin 33, Tumor Necrosis Factor alpha, Leptin and Glycosylated haemoglobin A1c (HbA1c)

Contacts

Primary ContactFrank HY Lai, Phd
frank.hy.lai@polyu.edu.hk91448014

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026